↓ Skip to main content

Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

Overview of attention for article published in BMC Endocrine Disorders, November 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
Published in
BMC Endocrine Disorders, November 2011
DOI 10.1186/1472-6823-11-18
Pubmed ID
Authors

Rajib K Bhattacharya, Mohit Khera, Gary Blick, Harvey Kushner, Dat Nguyen, Martin M Miner

Abstract

Recent evidence suggests that there may be a bidirectional, physiological link between hypogonadism and metabolic syndrome (MetS), and testosterone replacement therapy (TRT) has been shown to improve some symptoms of MetS in small patient populations. We examined the effect of 12 months of TRT on MetS components in a large cohort of hypogonadal men.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 3%
Spain 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Doctoral Student 4 10%
Student > Bachelor 4 10%
Other 3 8%
Professor 3 8%
Other 12 30%
Unknown 6 15%
Readers by discipline Count As %
Medicine and Dentistry 15 38%
Social Sciences 3 8%
Agricultural and Biological Sciences 2 5%
Physics and Astronomy 2 5%
Environmental Science 1 3%
Other 7 18%
Unknown 10 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2012.
All research outputs
#15,248,503
of 22,673,450 outputs
Outputs from BMC Endocrine Disorders
#392
of 737 outputs
Outputs of similar age
#96,431
of 141,745 outputs
Outputs of similar age from BMC Endocrine Disorders
#2
of 2 outputs
Altmetric has tracked 22,673,450 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 737 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,745 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.